Actinogen Medical Limited has released a press release.
Actinogen receives positive scientific advice from EMA
Earlier from Actinogen Medical
- Correction-March2026 quarterly activity report & Appendix 4C
- Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update
- ACW XanaMIA Alzheimers open label trial commences